Profile data is unavailable for this security.
About the company
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
- Revenue in USD (TTM)200.93m
- Net income in USD-18.90m
- Incorporated2008
- Employees376.00
- LocationSI-BONE Inc471 El Camino Real, Suite 101SANTA CLARA 95050United StatesUSA
- Phone+1 (408) 207-0700
- Fax+1 (408) 557-8312
- Websitehttps://si-bone.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories Inc | 247.54m | 3.73m | 515.13m | 730.00 | 144.10 | 2.76 | 17.92 | 2.08 | 0.6471 | 0.6471 | 44.81 | 33.79 | 0.5678 | 3.40 | 6.28 | 339,097.30 | 0.8564 | -8.81 | 1.13 | -9.71 | 62.40 | 61.98 | 1.51 | -25.15 | 1.45 | 1.62 | 0.4709 | -- | 11.47 | 15.41 | 99.22 | -- | 24.60 | 0.00 |
| Orthofix Medical Inc | 822.31m | -92.19m | 536.73m | 1.61k | -- | 1.18 | -- | 0.6527 | -2.34 | -2.34 | 20.76 | 11.30 | 0.943 | 1.42 | 6.08 | 512,343.90 | -10.57 | -12.43 | -13.13 | -15.38 | 68.83 | 69.37 | -11.21 | -12.99 | 1.43 | -1.66 | 0.2803 | -- | 2.85 | 15.13 | 26.83 | -- | 7.31 | -- |
| Varex Imaging Corp | 854.40m | -67.70m | 550.99m | 2.40k | -- | 1.16 | -- | 0.6449 | -1.63 | -1.63 | 19.34 | 11.38 | 0.7032 | 1.85 | 6.00 | 356,000.00 | -5.55 | -0.3327 | -6.45 | -0.3955 | 34.15 | 33.16 | -7.89 | -0.4661 | 1.87 | 2.22 | 0.4321 | -- | 4.14 | 2.73 | -47.38 | -- | -0.5159 | -- |
| Beta Bionics Inc | 100.25m | -73.20m | 555.66m | 420.00 | -- | 1.93 | -- | 5.54 | -1.95 | -1.95 | 2.48 | 6.48 | 0.4191 | 2.55 | 6.34 | 238,692.90 | -30.60 | -- | -34.34 | -- | 55.40 | -- | -73.02 | -- | 7.96 | -- | 0.00 | -- | 53.94 | -- | -33.68 | -- | -- | -- |
| Cytek Biosciences Inc | 201.49m | -66.54m | 569.48m | 702.00 | -- | 1.67 | -- | 2.83 | -0.5197 | -0.5197 | 1.58 | 2.66 | 0.4193 | 2.10 | 3.27 | 287,027.10 | -13.85 | -3.42 | -16.32 | -3.85 | 51.84 | 56.95 | -33.02 | -8.93 | 4.42 | -- | 0.0196 | -- | 0.5188 | 16.76 | -1,005.30 | -- | 22.05 | -- |
| Embecta Corp | 1.08bn | 139.50m | 591.61m | 1.85k | 4.22 | -- | 3.27 | 0.5479 | 2.37 | 2.37 | 18.31 | -10.35 | 0.9757 | 2.27 | 6.35 | 583,621.60 | 12.61 | 16.69 | 16.60 | 22.65 | 63.17 | 66.74 | 12.92 | 15.71 | 1.87 | 3.18 | 1.79 | 13.07 | -3.80 | -0.1033 | 21.84 | -25.93 | -26.03 | -- |
| Anteris Technologies Global Corp | 1.91m | -94.14m | 643.68m | 174.00 | -- | -- | -- | 336.47 | -2.54 | -2.54 | 0.0518 | -0.0022 | 0.0369 | 1.71 | 15.94 | 10,994.25 | -181.73 | -- | -285.52 | -- | 70.26 | -- | -4,925.51 | -- | 0.7263 | -117.66 | -- | -- | -29.23 | -- | -23.40 | -- | -- | -- |
| Avanos Medical Inc | 701.20m | -72.90m | 650.12m | 2.29k | -- | 0.8346 | -- | 0.9272 | -1.58 | -1.58 | 15.10 | 16.75 | 0.6295 | 2.42 | 6.06 | 306,602.50 | -6.54 | -5.81 | -7.69 | -6.58 | 50.47 | 53.66 | -10.40 | -12.67 | 1.26 | 11.11 | 0.1144 | -- | 1.95 | -0.3835 | 81.13 | -- | 9.36 | -- |
| Alpha Tau Medical Ltd | 0.00 | -39.97m | 650.57m | 125.00 | -- | 8.39 | -- | -- | -0.5212 | -0.5212 | 0.00 | 0.9099 | 0.00 | -- | -- | 0.00 | -40.90 | -34.28 | -44.43 | -36.47 | -- | -- | -- | -- | -- | -- | 0.0735 | -- | -- | -- | -8.89 | -- | 11.60 | -- |
| Tactile Systems Technology Inc | 329.52m | 19.09m | 657.24m | 1.09k | 35.09 | 3.00 | 25.54 | 1.99 | 0.8347 | 0.8347 | 14.21 | 9.76 | 1.15 | 9.92 | 7.42 | 303,427.30 | 6.67 | 2.68 | 7.79 | 3.21 | 50.79 | 49.70 | 5.79 | 2.58 | 3.69 | -- | 0.00 | 0.00 | 12.47 | 11.98 | 12.54 | -- | 2.04 | -- |
| CeriBell Inc | 89.06m | -53.41m | 683.56m | 327.00 | -- | 4.38 | -- | 7.68 | -1.46 | -1.46 | 2.44 | 4.14 | 0.4229 | 1.52 | 5.94 | 272,363.90 | -25.36 | -- | -27.46 | -- | 87.89 | -- | -59.97 | -- | 9.35 | -30.90 | 0.1131 | -- | 36.09 | -- | -32.03 | -- | -- | -- |
| SI-Bone Inc | 200.93m | -18.90m | 693.40m | 376.00 | -- | 3.86 | -- | 3.45 | -0.4418 | -0.4418 | 4.68 | 4.07 | 0.8568 | 1.35 | 7.00 | 534,375.00 | -8.06 | -20.29 | -9.08 | -22.64 | 79.57 | 81.28 | -9.41 | -29.99 | 7.21 | -- | 0.1669 | -- | 20.19 | 22.32 | 38.85 | -- | 26.86 | -- |
| Bioventus Inc | 563.83m | 7.82m | 725.83m | 950.00 | 78.07 | 4.37 | 12.65 | 1.29 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| Integra Lifesciences Holdings Corp | 1.64bn | -516.47m | 812.89m | 4.43k | -- | 0.7785 | -- | 0.4971 | -6.74 | -6.74 | 21.33 | 13.40 | 0.4281 | 1.54 | 5.93 | 369,379.90 | -13.52 | -0.5552 | -16.50 | -0.632 | 56.62 | 61.01 | -31.58 | -1.34 | 1.46 | 2.75 | 0.6401 | -- | 1.53 | 3.57 | -7,337.70 | -- | 8.40 | -- |
| Castle Biosciences Inc | 344.23m | -24.16m | 832.18m | 883.00 | -- | 1.76 | 50.09 | 2.42 | -0.8471 | -0.8471 | 11.81 | 15.86 | 0.6204 | 7.73 | 7.28 | 389,840.30 | -4.35 | -6.73 | -4.87 | -7.35 | 79.37 | 80.12 | -7.02 | -14.35 | 5.11 | -- | 0.0218 | -- | 3.66 | 40.60 | -232.41 | -- | 49.95 | -- |
| Inmode Ltd | 370.50m | 93.83m | 864.21m | 660.00 | 9.45 | 1.26 | 9.14 | 2.33 | 1.44 | 1.44 | 5.67 | 10.78 | 0.4774 | 1.19 | 9.28 | 561,356.10 | 12.09 | 24.21 | 13.30 | 26.82 | 78.54 | 82.36 | 25.33 | 38.64 | 8.83 | -- | 0.00 | 0.00 | -6.16 | 12.44 | -48.24 | 4.57 | 15.99 | -- |
Data as of Mar 03 2026. Currency figures normalised to SI-BONE Inc's reporting currency: US Dollar USD
48.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| First Light Asset Management LLCas of 31 Dec 2025 | 5.03m | 11.60% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 2.97m | 6.86% |
| Brown Advisory LLCas of 31 Dec 2025 | 2.46m | 5.67% |
| American Century Investment Management, Inc.as of 31 Dec 2025 | 2.30m | 5.30% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.19m | 5.04% |
| Silvercrest Asset Management Group LLCas of 31 Dec 2025 | 1.38m | 3.19% |
| Impax Asset Management LLCas of 31 Dec 2025 | 1.20m | 2.77% |
| Cadian Capital Management LPas of 31 Dec 2025 | 1.17m | 2.70% |
| Champlain Investment Partners LLCas of 31 Dec 2025 | 1.12m | 2.57% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.01m | 2.32% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
